Bifidobacterium Septicemia Associated with Postoperative Probiotic Therapy in a Neonate with Omphalocele - 07/03/14
Doi : 10.1016/j.jpeds.2009.11.041
Akira Ohishi, MD a, Shigehiro Takahashi, MD a, Yushi Ito, MD, PhD a, Yoshihisa Ohishi, MD a, Keiko Tsukamoto, MD a, Yukiko Nanba, MD, PhD a, Naoki Ito, MD a, Satsuki Kakiuchi, MD a, Akihiko Saitoh, MD, PhD b, Masami Morotomi, PhD c, Tomoo Nakamura, MD, PhD a, ⁎ 
a Division of Neonatology, National Center for Child Health and Development (NCCHD), Tokyo, Japan
b Department of Perinatal Medicine and Maternal Care, and the Division of Infectious Diseases, Department of Medical Specialties, National Center for Child Health and Development (NCCHD), Tokyo, Japan
c Yakult Central Institute for Microbiological Research, Tokyo, Japan
Reprint requests: Dr Tomoo Nakamura, Division of Neonatology, Department of Perinatal Medicine and Maternal Care, National Center for Child Health and Development (NCCHD), 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.Abstract |
We report the one case of sepsis caused by Bifidobacterium breve administered as probiotic therapy. Probiotics can be a potential cause of an invasive disease and should be used with care in vulnerable patients.
Le texte complet de cet article est disponible en PDF.Plan
| The authors declare no conflicts of interest. |
© 2010
Mosby, Inc. Tous droits réservés.
Vol 156 - N° 4
P. 679-681 - avril 2010 Retour au numéro
Article précédent
- Booster Vaccination After Neonatal Priming with Acellular Pertussis Vaccine
- Markus Knuf, Heinz-Josef Schmitt, Jeanne-Marie Jacquet, Alix Collard, Dorothee Kieninger, Claudius U. Meyer, Claire-Anne Siegrist, Fred Zepp
- Elevated Serum IL-8 Levels in Ataxia Telangiectasia
- Sharon A. McGrath-Morrow, J. Michael Collaco, Thomas O. Crawford, Kathryn A. Carson, Maureen A. Lefton-Greif, Pamela Zeitlin, Howard M. Lederman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?